1. Survivin Positivity and Prognostic Factors in Papillary Thyroid Carcinomas
- Author
-
Keskin, E. Usturali, Taştekin, E., Can, N., Mut, A.N., Celik, M., Bulbul, B. Yilmaz, Puyan, F. Oz, Ozyilmaz, F., Guldiken, S., Ayturk, S., Sezer, A., and Üstün, F.
- Subjects
Endocrinology ,Endocrine and Autonomic Systems ,Endocrinology, Diabetes and Metabolism ,General Endocrinology - Abstract
CONTEXT: Papillary thyroid carcinoma(PTC)s are the indolent progressive tumours. Survivin is a unique bifunctional protein with cell cycle regulation and apoptosis inhibition. The expression of this protein has been shown to be increased in thyroid tumours correlated with aggressive behavior from well differentiated to anaplastic. OBJECTIVE: In this study, we aimed to investigate the relationship between immunohistochemically survivin expression and tumour-associated prognostic factors in papillary thyroid carcinomas. DESIGN: In patients with thyroidectomy, we compared the clinicopathological findings and immunohistochemical positivity for survivin. SUBJECTS AND METHODS: In 109 patients, sex, age, tumour size, histological tumour variant, tumour focality, tumour border pattern, tumour peripheral/intratumoural lymphocytic and stromal response, intraglandular spread, extrathyroideal spread, lymph node metastases, lymphocytic tiroiditis and relationships of these findings with survivin positivity were investigated. RESULTS: When we indicated the tumour size and compared it with survivin expression, tumour size correlates with, survivin expression (p = 0.016). Survivin expression was correlated statistically significant with lymphovascular invasion, without stromal response and with intraglandular extension respectively (p
- Published
- 2021